{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:57:06Z","timestamp":1793825826018,"version":"4.6.1"},"reference-count":128,"publisher":"Journal of Biomedical Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2024]]},"DOI":"10.7555\/jbr.37.20220220","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T05:08:15Z","timestamp":1686200895000},"page":"122","source":"Crossref","is-referenced-by-count":22,"title":["Microglia in brain aging: An overview of recent basic science and clinical research developments"],"prefix":"10.7555","volume":"38","author":[{"given":"Haixia","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houchao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinshuang","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyou","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4380","reference":[{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.1","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, et al.  The hallmarks of aging[J]. <i>Cell<\/i>, 2013, 153(6): 1194\u20131217.","DOI":"10.1016\/j.cell.2013.05.039"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.2","unstructured":"Department of Economic and Social Affairs. World population ageing 2020 highlights[EB\/OL]. [2022-10-01]. <a href=\"https:\/\/www.un.org\/development\/desa\/pd\/news\/world-population-ageing-2020-highlights\/\">https:\/\/www.un.org\/development\/desa\/pd\/news\/world-population-ageing-2020-highlights\/<\/a>."},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.3","doi-asserted-by":"publisher","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes[J]. <i>Cell<\/i>, 1993, 72(6): 971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.4","doi-asserted-by":"publisher","unstructured":"Olde Rikkert MGM, Melis RJF, Cohen AA, et al.  Why illness is more important than disease in old age[J]. <i>Age Ageing<\/i>, 2022, 51(1): afab267.","DOI":"10.1093\/ageing\/afab267"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.5","doi-asserted-by":"publisher","unstructured":"Mattson MP, Arumugam TV.  Hallmarks of brain aging: adaptive and pathological modification by metabolic states[J]. <i>Cell Metab<\/i>, 2018, 27(6): 1176\u20131199.","DOI":"10.1016\/j.cmet.2018.05.011"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.6","doi-asserted-by":"publisher","unstructured":"Moca EN, Lecca D, Hope KT, et al.  Microglia drive pockets of neuroinflammation in middle age[J]. <i>J Neurosci<\/i>, 2022, 42(19): 3896\u20133918.","DOI":"10.1523\/JNEUROSCI.1922-21.2022"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.7","doi-asserted-by":"publisher","unstructured":"Spiteri AG, Wishart CL, Pamphlett R, et al.  Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function[J]. <i>Acta Neuropathol<\/i>, 2022, 143(2): 179\u2013224.","DOI":"10.1007\/s00401-021-02384-2"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.8","doi-asserted-by":"publisher","unstructured":"Zhao J, Ren T, Li X, et al.  Research progress on the role of microglia membrane proteins or receptors in neuroinflammation and degeneration[J]. <i>Front Cell Neurosci<\/i>, 2022, 16: 831977.","DOI":"10.3389\/fncel.2022.831977"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.9","doi-asserted-by":"publisher","unstructured":"Silvin A, Uderhardt S, Piot C, et al.  Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration[J]. <i>Immunity<\/i>, 2022, 55(8): 1448\u20131465.e6.","DOI":"10.1016\/j.immuni.2022.07.004"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.10","doi-asserted-by":"publisher","unstructured":"Frost JL, Schafer DP.  Microglia: architects of the developing nervous system[J]. <i>Trends Cell Biol<\/i>, 2016, 26(8): 587\u2013597.","DOI":"10.1016\/j.tcb.2016.02.006"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.11","doi-asserted-by":"publisher","unstructured":"Kierdorf K, Erny D, Goldmann T, et al.  Microglia emerge from erythromyeloid precursors <i>via<\/i> Pu. 1- and Irf8-dependent pathways[J]. <i>Nat Neurosci<\/i>, 2013, 16(3): 273\u2013280.","DOI":"10.1038\/nn.3318"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.12","doi-asserted-by":"publisher","unstructured":"Gomez Perdiguero E, Klapproth K, Schulz C, et al.  Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors[J]. <i>Nature<\/i>, 2015, 518(7540): 547\u2013551.","DOI":"10.1038\/nature13989"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.13","doi-asserted-by":"publisher","unstructured":"Ginhoux F, Greter M, Leboeuf M, et al.  Fate mapping analysis reveals that adult microglia derive from primitive macrophages[J]. <i>Science<\/i>, 2010, 330(6005): 841\u2013845.","DOI":"10.1126\/science.1194637"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.14","doi-asserted-by":"publisher","unstructured":"R\u00e9u P, Khosravi A, Bernard S, et al.  The lifespan and turnover of microglia in the human brain[J]. <i>Cell Rep<\/i>, 2017, 20(4): 779\u2013784.","DOI":"10.1016\/j.celrep.2017.07.004"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.15","doi-asserted-by":"crossref","unstructured":"Whalley K.  Neuronal neighbours tune microglial identity[J]. <i>Nat Rev Neurosci<\/i>, 2022, 23(10): 582\u2013583.","DOI":"10.1038\/s41583-022-00632-2"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.16","doi-asserted-by":"publisher","unstructured":"Yu Z, Fang X, Liu W, et al.  Microglia regulate blood-brain barrier integrity <i>via<\/i> MiR-126a-5p\/MMP9 Axis during inflammatory demyelination[J]. <i>Adv Sci (Weinh)<\/i>, 2022, 9(24): 2105442.","DOI":"10.1002\/advs.202105442"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.17","doi-asserted-by":"publisher","unstructured":"Smith BC, Tinkey RA, Shaw BC, et al.  Targetability of the neurovascular unit in inflammatory diseases of the central nervous system[J]. <i>Immunol Rev<\/i>, 2022, 311(1): 39\u201349.","DOI":"10.1111\/imr.13121"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.18","doi-asserted-by":"publisher","unstructured":"Du Y, Brennan FH, Popovich PG, et al.  Microglia maintain the normal structure and function of the hippocampal astrocyte network[J]. <i>GLIA<\/i>, 2022, 70(7): 1359\u20131379.","DOI":"10.1002\/glia.24179"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.19","doi-asserted-by":"publisher","unstructured":"Santos EN, Fields RD.  Regulation of myelination by microglia[J]. <i>Sci Adv<\/i>, 2021, 7(50): eabk1131.","DOI":"10.1126\/sciadv.abk1131"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.20","doi-asserted-by":"publisher","unstructured":"Nguyen PT, Dorman LC, Pan S, et al.  Microglial remodeling of the extracellular matrix promotes synapse plasticity[J]. <i>Cell<\/i>, 2020, 182(2): 388\u2013403.e15.","DOI":"10.1016\/j.cell.2020.05.050"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.21","doi-asserted-by":"publisher","unstructured":"Weinhard L, di Bartolomei G, Bolasco G, et al.  Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction[J]. <i>Nat Commun<\/i>, 2018, 9(1): 1228.","DOI":"10.1038\/s41467-018-03566-5"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.22","doi-asserted-by":"publisher","unstructured":"Boche D, Gordon MN.  Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease[J]. <i>Alzheimers Dement<\/i>, 2022, 18(2): 360\u2013376.","DOI":"10.1002\/alz.12389"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.23","doi-asserted-by":"publisher","unstructured":"Schwabenland M, Br\u00fcck W, Priller J, et al.  Analyzing microglial phenotypes across neuropathologies: a practical guide[J]. <i>Acta Neuropathol<\/i>, 2021, 142(6): 923\u2013936.","DOI":"10.1007\/s00401-021-02370-8"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.24","doi-asserted-by":"publisher","unstructured":"Nguyen HM, Gr\u00f6ssinger EM, Horiuchi M, et al.  Differential Kv1.3, KCa3.1, and Kir2.1 expression in \"classically\" and \"alternatively\" activated microglia[J]. <i>GLIA<\/i>, 2017, 65(1): 106\u2013121.","DOI":"10.1002\/glia.23078"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.25","doi-asserted-by":"publisher","unstructured":"Ransohoff RM.  A polarizing question: do M1 and M2 microglia exist?[J]. <i>Nat Neurosci<\/i>, 2016, 19(8): 987\u2013991.","DOI":"10.1038\/nn.4338"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.26","doi-asserted-by":"publisher","unstructured":"Zhou R, Qian S, Cho WCS, et al.  Microbiota-microglia connections in age-related cognition decline[J]. <i>Aging Cell<\/i>, 2022, 21(5): e13599.","DOI":"10.1111\/ACEL.13599"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.27","doi-asserted-by":"publisher","unstructured":"Mitra S, Banik A, Saurabh S, et al.  Neuroimmunometabolism: a new pathological nexus underlying neurodegenerative disorders[J]. <i>J Neurosci<\/i>, 2022, 42(10): 1888\u20131907.","DOI":"10.1523\/JNEUROSCI.0998-21.2022"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.28","doi-asserted-by":"publisher","unstructured":"Hou Y, Dan X, Babbar M, et al.  Ageing as a risk factor for neurodegenerative disease[J]. <i>Nat Rev Neurol<\/i>, 2019, 15(10): 565\u2013581.","DOI":"10.1038\/s41582-019-0244-7"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.29","doi-asserted-by":"publisher","unstructured":"de Paiva Lopes K, Snijders GJL, Humphrey J, et al.  Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies[J]. <i>Nat Genet<\/i>, 2022, 54(1): 4\u201317.","DOI":"10.1038\/s41588-021-00976-y"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.30","doi-asserted-by":"publisher","unstructured":"Shahidehpour RK, Higdon RE, Crawford NG, et al.  Dystrophic microglia are associated with neurodegenerative disease and not healthy aging in the human brain[J]. <i>Neurobiol Aging<\/i>, 2021, 99: 19\u201327.","DOI":"10.1016\/j.neurobiolaging.2020.12.003"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.31","doi-asserted-by":"publisher","unstructured":"Ohm DT, Fought AJ, Martersteck A, et al.  Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer's disease[J]. <i>Brain Pathol<\/i>, 2021, 31(1): 189\u2013204.","DOI":"10.1111\/bpa.12902"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.32","doi-asserted-by":"publisher","unstructured":"C\u00e1rdenas-Tueme M, Trujillo-Villarreal L\u00c1, Ram\u00edrez-Amaya V, et al.  Fornix volumetric increase and microglia morphology contribute to spatial and recognition-like memory decline in ageing male mice[J]. <i>NeuroImage<\/i>, 2022, 252: 119039.","DOI":"10.1016\/j.neuroimage.2022.119039"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.33","doi-asserted-by":"publisher","unstructured":"Lopes KO, Sparks DL, Streit WJ.  Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity[J]. <i>GLIA<\/i>, 2008, 56(10): 1048\u20131060.","DOI":"10.1002\/glia.20678"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.34","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Mend\u00edvil C, Luengo E, Trigo-Alonso P, et al.  Protective role of microglial HO-1 blockade in aging: implication of iron metabolism[J]. <i>Redox Biol<\/i>, 2021, 38: 101789.","DOI":"10.1016\/j.redox.2020.101789"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.35","doi-asserted-by":"publisher","unstructured":"Ko CJ, Gao SL, Lin TK, et al.  Ferroptosis as a major factor and therapeutic target for neuroinflammation in Parkinson's disease[J]. <i>Biomedicines<\/i>, 2021, 9(11): 1679.","DOI":"10.3390\/biomedicines9111679"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.36","doi-asserted-by":"publisher","unstructured":"Kenkhuis B, Somarakis A, de Haan L, et al.  Iron loading is a prominent feature of activated microglia in Alzheimer's disease patients[J]. <i>Acta Neuropathol Commun<\/i>, 2021, 9(1): 27.","DOI":"10.1186\/s40478-021-01126-5"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.37","doi-asserted-by":"publisher","unstructured":"Marschallinger J, Iram T, Zardeneta M, et al.  Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain[J]. <i>Nat Neurosci<\/i>, 2020, 23(2): 194\u2013208.","DOI":"10.1038\/s41593-019-0566-1"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.38","doi-asserted-by":"publisher","unstructured":"Elmore MRP, Hohsfield LA, Kram\u00e1r EA, et al.  Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice[J]. <i>Aging Cell<\/i>, 2018, 17(6): e12832.","DOI":"10.1111\/acel.12832"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.39","doi-asserted-by":"publisher","unstructured":"Niraula A, Sheridan JF, Godbout JP.  Microglia priming with aging and stress[J]. <i>Neuropsychopharmacology<\/i>, 2017, 42(1): 318\u2013333.","DOI":"10.1038\/npp.2016.185"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.40","doi-asserted-by":"publisher","unstructured":"Hu Y, Fryatt GL, Ghorbani M, et al.  Replicative senescence dictates the emergence of disease-associated microglia and contributes to A\u03b2 pathology[J]. <i>Cell Rep<\/i>, 2021, 35(10): 109228.","DOI":"10.1016\/j.celrep.2021.109228"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.41","doi-asserted-by":"publisher","unstructured":"Safaiyan S, Kannaiyan N, Snaidero N, et al.  Age-related myelin degradation burdens the clearance function of microglia during aging[J]. <i>Nat Neurosci<\/i>, 2016, 19(8): 995\u2013998.","DOI":"10.1038\/nn.4325"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.42","doi-asserted-by":"publisher","unstructured":"Gaband\u00e9-Rodr\u00edguez E, Keane L, Capasso M.  Microglial phagocytosis in aging and Alzheimer's disease[J]. <i>J Neurosci Res<\/i>, 2020, 98(2): 284\u2013298.","DOI":"10.1002\/jnr.24419"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.43","doi-asserted-by":"publisher","unstructured":"Wyss-Coray T.  Ageing, neurodegeneration and brain rejuvenation[J]. <i>Nature<\/i>, 2016, 539(7628): 180\u2013186.","DOI":"10.1038\/nature20411"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.44","doi-asserted-by":"publisher","unstructured":"Olah M, Patrick E, Villani AC, et al.  A transcriptomic atlas of aged human microglia[J]. <i>Nat Commun<\/i>, 2018, 9(1): 539.","DOI":"10.1038\/s41467-018-02926-5"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.45","doi-asserted-by":"publisher","unstructured":"Patel T, Carnwath TP, Wang X, et al.  Transcriptional landscape of human microglia implicates age, sex, and APOE-related immunometabolic pathway perturbations[J]. <i>Aging Cell<\/i>, 2022, 21(5): e13606.","DOI":"10.1111\/ACEL.13606"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.46","doi-asserted-by":"publisher","unstructured":"Brites D.  Regulatory function of microRNAs in microglia[J]. <i>GLIA<\/i>, 2020, 68(8): 1631\u20131642.","DOI":"10.1002\/glia.23846"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.47","doi-asserted-by":"publisher","unstructured":"Gong H, Chen H, Xiao P, et al.  miR-146a impedes the anti-aging effect of AMPK <i>via<\/i> NAMPT suppression and NAD+\/SIRT inactivation[J]. <i>Sig Transduct Target Ther<\/i>, 2022, 7(1): 66.","DOI":"10.1038\/s41392-022-00886-3"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.48","doi-asserted-by":"publisher","unstructured":"Liang C, Zou T, Zhang M, et al.  MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease[J]. <i>Theranostics<\/i>, 2021, 11(9): 4103\u20134121.","DOI":"10.7150\/thno.53418"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.49","doi-asserted-by":"publisher","unstructured":"Zhang L, Liao Y, Tang L.  MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer[J]. <i>J Exp Clin Cancer Res<\/i>, 2019, 38(1): 53.","DOI":"10.1186\/s13046-019-1059-5"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.50","doi-asserted-by":"publisher","unstructured":"Bazrgar M, Khodabakhsh P, Prudencio M, et al.  The role of microRNA-34 family in Alzheimer's disease: a potential molecular link between neurodegeneration and metabolic disorders[J]. <i>Pharmacol Res<\/i>, 2021, 172: 105805.","DOI":"10.1016\/j.phrs.2021.105805"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.51","doi-asserted-by":"publisher","unstructured":"Srinivasan AR, Tran TT, Bonini NM.  Loss of miR-34 in Drosophila dysregulates protein translation and protein turnover in the aging brain[J]. <i>Aging Cell<\/i>, 2022, 21(3): e13559.","DOI":"10.1111\/ACEL.13559"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.52","doi-asserted-by":"publisher","unstructured":"Kennerdell JR, Liu N, Bonini NM.  MiR-34 inhibits polycomb repressive complex 2 to modulate chaperone expression and promote healthy brain aging[J]. <i>Nat Commun<\/i>, 2018, 9(1): 4188.","DOI":"10.1038\/s41467-018-06592-5"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.53","doi-asserted-by":"publisher","unstructured":"Fenn AM, Smith KM, Lovett-Racke AE, et al.  Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand[J]. <i>Neurobiol Aging<\/i>, 2013, 34(12): 2748\u20132758.","DOI":"10.1016\/j.neurobiolaging.2013.06.007"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.54","doi-asserted-by":"publisher","unstructured":"Schmidt MF, Gan ZY, Komander D, et al.  Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities[J]. <i>Cell Death Differ<\/i>, 2021, 28(2): 570\u2013590.","DOI":"10.1038\/s41418-020-00706-7"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.55","doi-asserted-by":"publisher","unstructured":"Hansson O.  Biomarkers for neurodegenerative diseases[J]. <i>Nat Med<\/i>, 2021, 27(6): 954\u2013963.","DOI":"10.1038\/s41591-021-01382-x"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.56","doi-asserted-by":"publisher","unstructured":"GBD 2016 Neurology Collaborators.  Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016[J]. <i>Lancet Neurol<\/i>, 2019, 18(5): 459\u2013480.","DOI":"10.1016\/S1474-4422(18)30499-X"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.57","doi-asserted-by":"publisher","unstructured":"Brodaty H, Breteler MMB, Dekosky ST, et al.  The world of dementia beyond 2020[J]. <i>J Am Geriatr Soc<\/i>, 2011, 59(5): 923\u2013927.","DOI":"10.1111\/j.1532-5415.2011.03365.x"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.58","doi-asserted-by":"publisher","unstructured":"Bog\u00e1r F, F\u00fcl\u00f6p L, Penke B.  Novel therapeutic target for prevention of neurodegenerative diseases: modulation of neuroinflammation with Sig-1R ligands[J]. <i>Biomolecules<\/i>, 2022, 12(3): 363.","DOI":"10.3390\/biom12030363"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.59","doi-asserted-by":"publisher","unstructured":"Knopman DS, Amieva H, Petersen RC, et al.  Alzheimer disease[J]. <i>Nat Rev Dis Primers<\/i>, 2021, 7(1): 33.","DOI":"10.1038\/s41572-021-00269-y"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.60","doi-asserted-by":"crossref","unstructured":"2021 Alzheimer's disease facts and figures[J]. Alzheimers Dement, 2021, 17(3): 327\u2013406.","DOI":"10.1002\/alz.12328"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.61","doi-asserted-by":"publisher","unstructured":"Taipa R, Ferreira V, Brochado P, et al.  Inflammatory pathology markers (activated microglia and reactive astrocytes) in early and late onset Alzheimer disease: a post mortem study[J]. <i>Neuropathol Appl Neurobiol<\/i>, 2018, 44(3): 298\u2013313.","DOI":"10.1111\/nan.12445"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.62","doi-asserted-by":"publisher","unstructured":"Leng F, Edison P.  Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?[J]. <i>Nat Rev Neurol<\/i>, 2021, 17(3): 157\u2013172.","DOI":"10.1038\/s41582-020-00435-y"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.63","doi-asserted-by":"publisher","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, et al.  Microglial activation and tau propagate jointly across Braak stages[J]. <i>Nat Med<\/i>, 2021, 27(9): 1592\u20131599.","DOI":"10.1038\/s41591-021-01456-w"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.64","doi-asserted-by":"publisher","unstructured":"Clayton K, Delpech JC, Herron S, et al.  Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model[J]. <i>Mol Neurodegener<\/i>, 2021, 16(1): 18.","DOI":"10.1186\/s13024-021-00440-9"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.65","doi-asserted-by":"publisher","unstructured":"Wood H.  Alzheimer disease: evidence for trans-synaptic and exo-synaptic tau propagation in Alzheimer disease[J]. <i>Nat Rev Neurol<\/i>, 2015, 11(12): 665.","DOI":"10.1038\/nrneurol.2015.205"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.66","doi-asserted-by":"publisher","unstructured":"d'Errico P, Ziegler-Waldkirch S, Aires V, et al.  Microglia contribute to the propagation of A\u03b2 into unaffected brain tissue[J]. <i>Nat Neurosci<\/i>, 2022, 25(1): 20\u201325.","DOI":"10.1038\/s41593-021-00951-0"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.67","doi-asserted-by":"publisher","unstructured":"McFarland KN, Chakrabarty P.  Microglia in Alzheimer's disease: a key player in the transition between homeostasis and pathogenesis[J]. <i>Neurotherapeutics<\/i>, 2022, 19(1): 186\u2013208.","DOI":"10.1007\/s13311-021-01179-3"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.68","doi-asserted-by":"publisher","unstructured":"Gratuze M, Chen Y, Parhizkar S, et al.  Activated microglia mitigate A\u03b2-associated tau seeding and spreading[J]. <i>J Exp Med<\/i>, 2021, 218(8): e20210542.","DOI":"10.1084\/jem.20210542"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.69","doi-asserted-by":"crossref","unstructured":"Hamelin L, Lagarde J, Doroth\u00e9e G, et al.  Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging[J]. <i>Brain<\/i>, 2016, 139(Pt 4): 1252\u20131264.","DOI":"10.1093\/brain\/aww017"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.70","doi-asserted-by":"publisher","unstructured":"Zhang L, Hu K, Shao T, et al.  Recent developments on PET radiotracers for TSPO and their applications in neuroimaging[J]. <i>Acta Pharm Sin B<\/i>, 2021, 11(2): 373\u2013393.","DOI":"10.1016\/j.apsb.2020.08.006"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.71","doi-asserted-by":"publisher","unstructured":"Hamelin L, Lagarde J, Doroth\u00e9e G, et al.  Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease[J]. <i>Brain<\/i>, 2018, 141(6): 1855\u20131870.","DOI":"10.1093\/brain\/awy079"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.72","doi-asserted-by":"publisher","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, et al.  A unique microglia type associated with restricting development of Alzheimer's Disease[J]. <i>Cell<\/i>, 2017, 169(7): 1276\u20131290.e17.","DOI":"10.1016\/j.cell.2017.05.018"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.73","doi-asserted-by":"crossref","unstructured":"Lempriere S.  TREM2 response occurs early in amyloid cascade[J]. <i>Nat Rev Neurol<\/i>, 2022, 18(5): 251.","DOI":"10.1038\/s41582-022-00658-1"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.74","doi-asserted-by":"publisher","unstructured":"Gratuze M, Leyns CEG, Sauerbeck AD, et al.  Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration[J]. <i>J Clin Invest<\/i>, 2020, 130(9): 4954\u20134968.","DOI":"10.1172\/JCI138179"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.75","doi-asserted-by":"publisher","unstructured":"Kim B, Suh E, Nguyen AT, et al.  TREM2 risk variants are associated with atypical Alzheimer's disease[J]. <i>Acta Neuropathol<\/i>, 2022, 144(6): 1085\u20131102.","DOI":"10.1007\/s00401-022-02495-4"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.76","doi-asserted-by":"publisher","unstructured":"Yeh FL, Hansen DV, Sheng M.  TREM2, microglia, and neurodegenerative diseases[J]. <i>Trends Mol Med<\/i>, 2017, 23(6): 512\u2013533.","DOI":"10.1016\/j.molmed.2017.03.008"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.77","doi-asserted-by":"publisher","unstructured":"Roda AR, Serra-Mir G, Montoliu-Gaya L, et al.  Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease[J]. <i>Neural Regen Res<\/i>, 2022, 17(8): 1666\u20131674.","DOI":"10.4103\/1673-5374.332127"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.78","doi-asserted-by":"crossref","unstructured":"Fan Z, Brooks DJ, Okello A, et al.  An early and late peak in microglial activation in Alzheimer's disease trajectory[J]. <i>Brain<\/i>, 2017, 140(3): 792\u2013803.","DOI":"10.1093\/brain\/aww349"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.79","doi-asserted-by":"publisher","unstructured":"Bloem BR, Okun MS, Klein C.  Parkinson's disease[J]. <i>Lancet<\/i>, 2021, 397(10291): 2284\u20132303.","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.80","doi-asserted-by":"publisher","unstructured":"Aarsland D, Batzu L, Halliday GM, et al.  Parkinson disease-associated cognitive impairment[J]. <i>Nat Rev Dis Primers<\/i>, 2021, 7(1): 47.","DOI":"10.1038\/s41572-021-00280-3"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.81","doi-asserted-by":"publisher","unstructured":"Raza C, Anjum R, Shakeel NUA.  Parkinson's disease: mechanisms, translational models and management strategies[J]. <i>Life Sci<\/i>, 2019, 226: 77\u201390.","DOI":"10.1016\/j.lfs.2019.03.057"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.82","doi-asserted-by":"publisher","unstructured":"Gerhard A, Pavese N, Hotton G, et al.  In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease[J]. <i>Neurobiol Dis<\/i>, 2006, 21(2): 404\u2013412.","DOI":"10.1016\/j.nbd.2005.08.002"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.83","doi-asserted-by":"publisher","unstructured":"Duffy MF, Collier TJ, Patterson JR, et al.  Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration[J]. <i>J Neuroinflammation<\/i>, 2018, 15(1): 129.","DOI":"10.1186\/s12974-018-1171-z"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.84","doi-asserted-by":"publisher","unstructured":"Lavisse S, Goutal S, Wimberley C, et al.  Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging[J]. <i>Parkinsonism Relat Disord<\/i>, 2021, 82: 29\u201336.","DOI":"10.1016\/j.parkreldis.2020.11.011"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.85","doi-asserted-by":"publisher","unstructured":"Li Y, Xia Y, Yin S, et al.  Targeting microglial \u03b1-Synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson's disease[J]. <i>Front Immunol<\/i>, 2021, 12: 719807.","DOI":"10.3389\/fimmu.2021.719807"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.86","doi-asserted-by":"publisher","unstructured":"Scheiblich H, Bousset L, Schwartz S, et al.  Microglial NLRP3 inflammasome activation upon TLR2 and TLR5 ligation by distinct \u03b1-synuclein assemblies[J]. <i>J Immunol<\/i>, 2021, 207(8): 2143\u20132154.","DOI":"10.4049\/jimmunol.2100035"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.87","doi-asserted-by":"publisher","unstructured":"Bido S, Muggeo S, Massimino L, et al.  Microglia-specific overexpression of \u03b1-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity[J]. <i>Nat Commun<\/i>, 2021, 12(1): 6237.","DOI":"10.1038\/s41467-021-26519-x"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.88","doi-asserted-by":"publisher","unstructured":"Sun MF, Shen YQ.  Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease[J]. <i>Ageing Res Rev<\/i>, 2018, 45: 53\u201361.","DOI":"10.1016\/j.arr.2018.04.004"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.89","doi-asserted-by":"publisher","unstructured":"Bi M, Feng L, He J, et al.  Emerging insights between gut microbiome dysbiosis and Parkinson's disease: pathogenic and clinical relevance[J]. <i>Ageing Res Rev<\/i>, 2022, 82: 101759.","DOI":"10.1016\/j.arr.2022.101759"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.90","doi-asserted-by":"publisher","unstructured":"Wang Q, Luo Y, Ray Chaudhuri K, et al.  The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options[J]. <i>Brain<\/i>, 2021, 144(9): 2571\u20132593.","DOI":"10.1093\/brain\/awab156"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.91","doi-asserted-by":"publisher","unstructured":"Wang W, Jiang S, Xu C, et al.  Interactions between gut microbiota and Parkinson's disease: the role of microbiota-derived amino acid metabolism[J]. <i>Front Aging Neurosci<\/i>, 2022, 14: 976316.","DOI":"10.3389\/fnagi.2022.976316"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.92","doi-asserted-by":"publisher","unstructured":"Sampson TR, Debelius JW, Thron T, et al.  Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease[J]. <i>Cell<\/i>, 2016, 167(6): 1469\u20131480.e12.","DOI":"10.1016\/j.cell.2016.11.018"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.93","doi-asserted-by":"publisher","unstructured":"Rai SN, Singh P.  Advancement in the modelling and therapeutics of Parkinson's disease[J]. <i>J Chem Neuroanat<\/i>, 2020, 104: 101752.","DOI":"10.1016\/j.jchemneu.2020.101752"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.94","doi-asserted-by":"publisher","unstructured":"Rai SN, Singh P, Varshney R, et al.  Promising drug targets and associated therapeutic interventions in Parkinson's disease[J]. <i>Neural Regen Res<\/i>, 2021, 16(9): 1730\u20131739.","DOI":"10.4103\/1673-5374.306066"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.95","doi-asserted-by":"publisher","unstructured":"Rai SN, Chaturvedi VK, Singh P, et al.  Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective[J]. <i>3 Biotech<\/i>, 2020, 10(12): 522.","DOI":"10.1007\/s13205-020-02532-7"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.96","doi-asserted-by":"publisher","unstructured":"Rai SN, Birla H, Singh SS, et al.  Mucuna pruriens protects against MPTP intoxicated neuroinflammation in Parkinson's disease through NF-\u03baB\/pAKT signaling pathways[J]. <i>Front Aging Neurosci<\/i>, 2017, 9: 421.","DOI":"10.3389\/fnagi.2017.00421"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.97","doi-asserted-by":"publisher","unstructured":"Rai SN, Zahra W, Singh SS, et al.  Anti-inflammatory activity of ursolic acid in MPTP-induced parkinsonian mouse model[J]. <i>Neurotox Res<\/i>, 2019, 36(3): 452\u2013462.","DOI":"10.1007\/s12640-019-00038-6"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.98","doi-asserted-by":"publisher","unstructured":"Singh SS, Rai SN, Birla H, et al.  Neuroprotective effect of chlorogenic acid on mitochondrial dysfunction-mediated apoptotic death of DA neurons in a Parkinsonian mouse model[J]. <i>Oxid Med Cell Longev<\/i>, 2020, 2020: 6571484.","DOI":"10.1155\/2020\/6571484"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.99","doi-asserted-by":"publisher","unstructured":"Prakash J, Chouhan S, Yadav SK, et al.  Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons[J]. <i>Neurochem Res<\/i>, 2014, 39(12): 2527\u20132536.","DOI":"10.1007\/s11064-014-1443-7"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.100","doi-asserted-by":"publisher","unstructured":"Wang Y, Tong Q, Ma S, et al.  Oral berberine improves brain dopa\/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota[J]. <i>Sig Transduct Target Ther<\/i>, 2021, 6(1): 77.","DOI":"10.1038\/s41392-020-00456-5"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.101","doi-asserted-by":"publisher","unstructured":"Ross CA, Aylward EH, Wild EJ, et al.  Huntington disease: natural history, biomarkers and prospects for therapeutics[J]. <i>Nat Rev Neurol<\/i>, 2014, 10(4): 204\u2013216.","DOI":"10.1038\/nrneurol.2014.24"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.102","doi-asserted-by":"publisher","unstructured":"Behl T, Kaur G, Sehgal A, et al.  Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: pathophysiological and therapeutic perspectives[J]. <i>Int J Mol Sci<\/i>, 2021, 22(3): 1413.","DOI":"10.3390\/ijms22031413"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.103","doi-asserted-by":"publisher","unstructured":"Rocha NP, Charron O, Latham LB, et al.  Microglia activation in basal ganglia is a late event in Huntington disease pathophysiology[J]. <i>Neurol Neuroimmunol Neuroinflamm<\/i>, 2021, 8(3): e984.","DOI":"10.1212\/NXI.0000000000000984"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.104","doi-asserted-by":"publisher","unstructured":"Savage JC, St-Pierre MK, Carrier M, et al.  Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington's disease pathology[J]. <i>J Neuroinflammation<\/i>, 2020, 17(1): 98.","DOI":"10.1186\/s12974-020-01782-9"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.105","doi-asserted-by":"publisher","unstructured":"Connolly C, Magnusson-Lind A, Lu G, et al.  Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin[J]. <i>Neuroscience<\/i>, 2016, 325: 74\u201388.","DOI":"10.1016\/j.neuroscience.2016.03.031"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.106","doi-asserted-by":"publisher","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, et al.  Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis[J]. <i>Lancet Neurol<\/i>, 2022, 21(5): 480\u2013493.","DOI":"10.1016\/S1474-4422(21)00465-8"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.107","doi-asserted-by":"publisher","unstructured":"Xu L, Liu T, Liu L, et al.  Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis[J]. <i>J Neurol<\/i>, 2020, 267(4): 944\u2013953.","DOI":"10.1007\/s00415-019-09652-y"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.108","doi-asserted-by":"publisher","unstructured":"Brown RH, Al-Chalabi A.  Amyotrophic lateral sclerosis[J]. <i>N Engl J Med<\/i>, 2017, 377(2): 162\u2013172.","DOI":"10.1056\/NEJMra1603471"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.109","doi-asserted-by":"publisher","unstructured":"Quek H, Cun\u00ed-L\u00f3pez C, Stewart R, et al.  ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression[J]. <i>J Neuroinflammation<\/i>, 2022, 19(1): 58.","DOI":"10.1186\/s12974-022-02421-1"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.110","doi-asserted-by":"publisher","unstructured":"Dols-Icardo O, Montal V, Sirisi S, et al.  Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis[J]. <i>Neurol Neuroimmunol Neuroinflamm<\/i>, 2020, 7(5): e829.","DOI":"10.1212\/NXI.0000000000000829"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.111","doi-asserted-by":"publisher","unstructured":"Alshikho MJ, Z\u00fcrcher NR, Loggia ML, et al.  Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis[J]. <i>Neurology<\/i>, 2016, 87(24): 2554\u20132561.","DOI":"10.1212\/WNL.0000000000003427"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.112","doi-asserted-by":"publisher","unstructured":"Brettschneider J, Toledo JB, Van Deerlin VM, et al.  Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis[J]. <i>PLoS One<\/i>, 2012, 7(6): e39216.","DOI":"10.1371\/journal.pone.0039216"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.113","doi-asserted-by":"publisher","unstructured":"Paolicelli RC, Jawaid A, Henstridge CM, et al.  TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss[J]. <i>Neuron<\/i>, 2017, 95(2): 297\u2013308.e6.","DOI":"10.1016\/j.neuron.2017.05.037"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.114","doi-asserted-by":"publisher","unstructured":"Reyes-Leiva D, Dols-Icardo O, Sirisi S, et al.  Pathophysiological underpinnings of extra-motor neurodegeneration in amyotrophic lateral sclerosis: new insights from biomarker studies[J]. <i>Front Neurol<\/i>, 2022, 12: 750543.","DOI":"10.3389\/fneur.2021.750543"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.115","doi-asserted-by":"publisher","unstructured":"Mu\u00f1oz-Esp\u00edn D, Serrano M.  Cellular senescence: from physiology to pathology[J]. <i>Nat Rev Mol Cell Biol<\/i>, 2014, 15(7): 482\u2013496.","DOI":"10.1038\/nrm3823"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.116","doi-asserted-by":"publisher","unstructured":"Childs BG, Gluscevic M, Baker DJ, et al.  Senescent cells: an emerging target for diseases of ageing[J]. <i>Nat Rev Drug Discov<\/i>, 2017, 16(10): 718\u2013735.","DOI":"10.1038\/nrd.2017.116"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.117","doi-asserted-by":"publisher","unstructured":"Si Z, Sun L, Wang X.  Evidence and perspectives of cell senescence in neurodegenerative diseases[J]. <i>Biomed Pharmacother<\/i>, 2021, 137: 111327.","DOI":"10.1016\/j.biopha.2021.111327"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.118","doi-asserted-by":"publisher","unstructured":"Goldmann T, Wieghofer P, Jord\u00e3o MJC, et al.  Origin, fate and dynamics of macrophages at central nervous system interfaces[J]. <i>Nat Immunol<\/i>, 2016, 17(7): 797\u2013805.","DOI":"10.1038\/ni.3423"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.119","doi-asserted-by":"publisher","unstructured":"Spittau B.  Aging microglia-phenotypes, functions and implications for age-related neurodegenerative diseases[J]. <i>Front Aging Neurosci<\/i>, 2017, 9: 194.","DOI":"10.3389\/fnagi.2017.00194"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.120","doi-asserted-by":"publisher","unstructured":"Davies DS, Ma J, Jegathees T, et al.  Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer's disease[J]. <i>Brain Pathol<\/i>, 2017, 27(6): 795\u2013808.","DOI":"10.1111\/bpa.12456"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.121","doi-asserted-by":"publisher","unstructured":"Mrdjen D, Pavlovic A, Hartmann FJ, et al.  High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease[J]. <i>Immunity<\/i>, 2018, 48(3): 599.","DOI":"10.1016\/j.immuni.2018.02.014"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.122","doi-asserted-by":"publisher","unstructured":"Gorgoulis V, Adams PD, Alimonti A, et al.  Cellular senescence: defining a path forward[J]. <i>Cell<\/i>, 2019, 179(4): 813\u2013827.","DOI":"10.1016\/j.cell.2019.10.005"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.123","doi-asserted-by":"publisher","unstructured":"Baker DJ, Petersen RC.  Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives[J]. <i>J Clin Invest<\/i>, 2018, 128(4): 1208\u20131216.","DOI":"10.1172\/JCI95145"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.124","doi-asserted-by":"publisher","unstructured":"Wendimu MY, Hooks SB.  Microglia phenotypes in aging and neurodegenerative diseases[J]. <i>Cells<\/i>, 2022, 11(13).","DOI":"10.3390\/cells11132091"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.125","doi-asserted-by":"publisher","unstructured":"Kiss T, Ny\u00fal-T\u00f3th \u00c1, DelFavero J, et al.  Spatial transcriptomic analysis reveals inflammatory foci defined by senescent cells in the white matter, hippocampi and cortical grey matter in the aged mouse brain[J]. <i>Geroscience<\/i>, 2022, 44(2): 661\u2013681.","DOI":"10.1007\/s11357-022-00521-7"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.126","doi-asserted-by":"publisher","unstructured":"Hammond TR, Dufort C, Dissing-Olesen L, et al.  Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes[J]. <i>Immunity<\/i>, 2019, 50(2): 253\u2013271.e6.","DOI":"10.1016\/j.immuni.2018.11.004"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.127","doi-asserted-by":"crossref","unstructured":"Ogrodnik M, Evans SA, Fielder E, et al.  Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice[J]. <i>Aging Cell<\/i>, 2021, 20(2): e13296.","DOI":"10.1111\/acel.13296"},{"key":"10.7555\/JBR.37.20220220.swyxyjzzywb.128","doi-asserted-by":"publisher","unstructured":"Bussian TJ, Aziz A, Meyer CF, et al.  Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline[J]. <i>Nature<\/i>, 2018, 562(7728): 578\u2013582.","DOI":"10.1038\/s41586-018-0543-y"}],"container-title":["The Journal of Biomedical Research"],"original-title":[],"link":[{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.37.20220220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T02:24:15Z","timestamp":1717122255000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.37.20220220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"alternative-id":["JBR-2022-0220"],"URL":"https:\/\/doi.org\/10.7555\/jbr.37.20220220","relation":{},"ISSN":["1674-8301","1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"},{"value":"1674-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}